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Leptomonas seymouri and Crithidia fasciculata exoantigens 
can discriminate human cases of visceral leishmaniasis from 
American tegumentary leishmaniasis ones
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ABSTRACT 
Exoantigens (exo) from Leptomonas seymouri and Crithidia fasciculata were used 
in an enzyme linked immunosorbent assay (ELISA), showing 100% reactivity with sera 
from visceral leishmaniasis (VL) cases, and no reactivity with American tegumentary 
leishmaniasis (ATL) ones. Our results have indicated that these exoantigens can be applied 
in the discrimination of VL and ATL cases. 
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SHORT COMMUNICATION 
Within the Trypanosomatidae family, plant and insect trypanosomatids have 
been used as laboratory models for biochemistry and molecular biology studies 
as they share homologous molecules with pathogenic species such as Leishmania 
spp. and Trypanosoma cruzi, the causative agents of leishmaniasis and Chagas 
disease, respectively1-4. The high degree of conserved antigens between plant and 
insect trypanosomatids may explain their cross-immunoreactivity with sera from 
Chagas disease (CD)5-8, visceral leishmaniasis (VL)6,9-11 and American tegumentary 
leishmaniasis (ATL) patients6,12. To date few studies have investigated this interesting 
feature of trypanosomatids, the majority being limited to phylogenetic analyses13.
Despite the numerous studies on exoantigens of insect and plant 
trypanosomatids1,3,4,14, the immunogenicity of these protozoans and the fact that 
they can be recognized by anti-Leishmania spp. and anti-T. cruzi antibodies has 
been overlooked. In contrast, exoantigens of T. cruzi15, and Leishmania spp16 have 
been studied, have performed well in the diagnosis of CD17,18, and have also been 
promising for the diagnosis of VL19-21 and ATL20-23. 
In this study, exoantigens from the insect trypanosomatids L. seymouri and 
C. fasciculata were tested by ELISA to evaluate the reactivity of IgG antibodies 
from patients with CD, VL and ATL. 
Exoantigens from L. seymouri (TCC011E) and C. fasciculata (TCC039) were 
obtained as previously described for excreted-secreted antigens (ESA) of L. (L.) 
infantum chagasi20 (MHOM/BR/1972/LD). Briefly, exoantigens from L. seymouri 
and C. fasciculata were recovered from RPMI-1640 medium containing 1-5 x 108 
cultured parasites/mL after incubation for 24 h at 26 °C without agitation, and stored 
in small aliquots at -40 °C. They were then used without any further purification. 
None of the exoantigen batches contained tubulin molecules that may have been 
Kesper et al.
Rev Inst Med Trop São Paulo. 2017;59:e1Page 2 of 4
released from the lysed parasites, as attested by the absence 
of reactivity with a monoclonal anti-α tubulin antibody (data 
not shown). Trypomastigote excreted-secreted antigens 
(TESA) of T. cruzi (Y strain) were obtained as described 
elsewhere17. Alkaline extracts (AEs) from L. seymouri, 
C. fasciculata and L. (L.) infantum chagasi promastigotas 
and T. cruzi epimastigotes were prepared as previously 
described6,18,20. Briefly, the parasite pellets were solubilized 
in 0.3 N NaOH for 18 h at 4 °C, neutralized with 0.3 N HCl 
to pH 7-8, and centrifuged at 12,000 g for 1 min. at 4 °C. 
The protein concentration of the supernatants was quantified 
(Macro-bicinchoninic acid protein assay reagent kit; Pierce 
Co, Rockford, USA) and aliquots were stored at -20 °C. 
ELISAs were performed as previously described6,20 
using diluted sera 1:200 and incubated with 4 µg/mL of 
AEs from the parasites analyzed and with 2 mg/mL of 
exoantigens from L. seymouri and C. fasciculata, and 
1 mg/mL of ESA from L. (L.) infantum chagasi and TESA. 
Serum samples were recorded as positive or negative based 
on the cut-off values calculated from the receiver operating 
characteristics (ROC) for sera collected from 20 healthy 
blood donors from endemic and non-endemic areas of CD 
and Leishmania spp. 
One-way analysis of variance with Bonferroni multiple 
comparison adjustment was used to compare the mean 
titers from the evaluated antigens and parasites. The results 
were considered significant when p < 0.05 with a 95% 
confidence interval. Statistical analyses were performed 
with the GraphPad Prism 3.0 for Windows (GraphPad 
Software, USA).
Figure 1 shows the reactivity of serum IgG antibodies 
according to the antigenic preparation and results were 
expressed as the absorbance at 492 nm (Abs492 nm). Data 
from ELISA-Exo revealed that molecules released from 
L. seymouri and C. fasciculata reacted with all of the sera 
(n=30) from patients with active VL, living in the State 
of Piauí, Brazil, whose clinical and diagnostic data had 
been previously reported24, and the reactivity was similar 
to that obtained with ESA from L. (L.) infantum chagasi 
(Fig. 1A, Table 1), with no statistical difference between 
the two tests results (p > 0.05), while TESA from T. cruzi 
cross-reacted with only 13% of the sera from VL patients 
(Fig. 1A, Table 1). AEs from L. seymouri, C. fasciculata 
and L. (L.) infantum chagasi reacted with IgG antibodies 
from 100% of VL cases, with no statistical difference 
among them (p > 0.05), while AE from T. cruzi reacted with 
93% of VL cases (Fig 1B, Table 1), confirming previously 
described data6. 
It is known that antibodies found in VL cases show a 
high degree of cross-reactivity with antigens of different 
trypanosome species6,20. Indeed, several authors found 
that serological methods for the detection of VL or ATL 
cases failed to discriminate between VL and ATL, even 
with the use of species-specific antigens12,20,25. Thirty-two 
sera from Brazilian ATL patients from the Instituto de 
Infectologia Emílio Ribas in São Paulo, presenting with 
clinical diagnosis, as well as a positive Montenegro skin test 
and identification of the parasites in either skin or mucosal 
biopsies showed no reactivity with exoantigens from 
L. seymouri or C. fasciculata, while 53% of them reacted 
with ESA from L. (L.) infantum chagasi, a significant 
statistical difference (p < 0.05), and 13% reacted with TESA 
from T. cruzi although titers were lower (Fig. 1A, Table 1). 
ATL sera cross-reacted with AE from L. seymouri (63%), 
C. fasciculata (56%), L. (L.) infantum chagasi (66%) and 
Figure 1 - Box-and-whisker plots of levels of specific IgG 
antibodies against Exo, ESA, TESA (A) and AE antigens (B) 
of L. seymouri, C. fasciculata, L. (L.) infantum chagasi and T. 
cruzi expressed as the absorbance at 492 nm (Abs 492 nm) 
in sera from patients with human visceral leishmaniasis (VL), 
American tegumentary leishmaniasis (ATL), Chagas disease 
(CD) and other diseases (OD), as well as in sera from healthy 
individuals (H). The horizontal line inside the box-whisker plot 
indicates the median.
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T. cruzi (77%), with no statistical difference among them 
(p > 0.05) (Fig 1B, Table 1). 
In this study, exoantigens from C. fasciculata and L. 
seymouri did not exhibit antigenic molecules that react with 
ATL antibodies, however, it was not possible to determine 
the Leishmania species causing lesions in our casuistic so 
as to affirm that the results presented herewith could be 
extended for all species occurring in Brazil. Nonetheless, 
our results have suggested that these exoantigens may 
constitute a potential alternative for discriminating between 
VL and ATL. 
Cross-reactivity was evaluated using sera from 27 
chronic CD patients whose positivity was confirmed by 
serology. High reactivity levels were observed with AEs 
from L. seymouri and C. fasciculata (96%) and L. (L.) 
infantum chagasi (100%) with no statistical difference 
among them (p > 0.05), while for T. cruzi (100%) higher 
mean titers (p < 0.05) were detected (Fig 1B, Table 1).
A total of 56% and 63% of these sera were reactive to 
exoantigens from L. seymouri and C. fasciculata (p > 0.05); 
and 41% with ESA from L. (L.) infantum chagasi (p < 0.05); 
while reactivity was 100% with TESA (Fig. 1A, Table 1).
Despite the cross-reactivity with sera from CD 
patients, the mean ELISA titers using non-pathogenic 
trypanosomatid antigens were always lower (p < 0.05) when 
compared to the ones from ELISA using T. cruzi antigens. 
As expected, none of the 29 sera from patients with 
other diseases (OD), as defined by clinical, epidemiological 
and serological diagnosis (4 with toxoplasmosis, 4 with 
malaria, 4 with schistosomiasis, 6 with tuberculosis, 5 with 
autoimmune diseases (presence of antinuclear antibodies), 
3 with histoplasmosis and 3 with toxocariasis, or 20 healthy 
(H) blood donors, showed cross-reactivity with exoantigens, 
ESA, TESA or AE antigens (Fig. 1A, B; Table 1).
This finding represents an advance in the study of 
diagnostic techniques for leishmaniasis and it opens up 
the possibility of using molecules released by L. seymouri 
and C. fasciculata in the ELISA format to develop a 
rapid, accurate and sensitive diagnostic procedure for 
differentiating between VL and ATL. Moreover, insect 
trypanosomatids are non-pathogenic to humans and could 
be used instead of pathogenic Leishmania species. The 
ability to differentiate infection caused by dermotropic 
Leishmania from viscerotropic Leishmania in areas where 
there is an overlap of these parasites, and also the fact 
that this antigen could be also applied to seroprevalence 
studies in non-endemic areas for T. cruzi are very exciting. 
However, future accuracy studies in larger populations 
must be conducted in order to state the real utility of the 
tested techniques.
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